Close

 

Fund Holdings (%)1,2 as of Feb 28, 2025

Holding % of Net Assets
Eli Lilly & Co 11.14%
AbbVie Inc 6.36%
Novo Nordisk A/S 5.24%
AstraZeneca PLC 4.92%
Abbott Laboratories 4.53%
UnitedHealth Group Inc 4.21%
Roche Holding AG 4.20%
Bristol-Myers Squibb Co 3.66%
Thermo Fisher Scientific Inc 3.58%
Intuitive Surgical Inc 3.56%
Johnson & Johnson 3.44%
Zoetis Inc 3.14%
Boston Scientific Corp 2.92%
Gilead Sciences Inc 2.63%
Sanofi 2.50%
Danaher Corp 2.49%
Vertex Pharmaceuticals Inc 2.48%
CSL Ltd 1.92%
McKesson Corp 1.79%
Lonza Group AG 1.47%
Edwards Lifesciences Corp 1.47%
IDEXX Laboratories Inc 1.46%
Mettler-Toledo International Inc 1.39%
Humana Inc 1.32%
Neurocrine Biosciences Inc 1.26%
Merck & Co Inc 1.19%
Cooper Cos Inc 1.18%
Alcon AG 1.18%
Stryker Corp 1.17%
Royalty Pharma PLC 1.10%
Straumann Holding AG 1.00%
Centene Corp 0.97%
ARGENX SE - ADR 0.97%
SPDR S&P Biotech ETF 0.94%
Coloplast A/S 0.88%
Amplifon SpA 0.81%
Align Technology Inc 0.79%
Sartorius AG 0.78%
Teleflex Inc 0.70%
AptarGroup Inc 0.67%
Option Care Health Inc 0.61%
Illumina Inc 0.54%
Asahi Intecc Co Ltd 0.43%
Newamsterdam Pharma Co NV 0.25%
iShares Global Healthcare ETF 0.19%
JMDC Inc 0.17%
MSILF GOVERNMENT PORTFOLIO MSILF GOVERNMENT PORTFOLIO 0.11%
CARIS LIFE SCIENCES, INC 0.06%